BIOTECH
Governance-native AI infrastructure for biopharm R&D, cell and gene therapy developers, and contract research
Constitutional RuntimeWho this is for
Biopharmaceutical research and translational teams, cell and gene therapy developers, biologics manufacturers, contract research and contract development organizations, and preclinical and clinical operations groups deploying AI where a wrong answer touches an experimental record, a batch history, a protocol amendment, or a regulatory submission. ETHRAEON provides constitutional runtime posture. Sponsor and site regulatory responsibility remains with the organization operating the study.
- Biopharm R&D and translational science organizations
- Cell and gene therapy developers and process-development teams
- Contract research organizations and contract development and manufacturing organizations
- Preclinical, clinical operations, and regulatory affairs teams
- Biobank, biorepository, and specimen-tracking operations
Capability surface
Constitutional runtime
The PRAXIS 7-Gate pipeline enforces governance on every AI action. It stops when unsure. Evidence is mandatory. Defaults deny rather than guess. Experimental reasoning, protocol drafting, and batch-history workflows inherit this posture by construction, not by policy overlay.
Experimental and batch evidence
Every AI action against an experimental record, electronic lab notebook entry, batch history, or process-development artifact records to a tamper-evident, SHA-256 hash-chained evidence store. Sponsor audit, regulatory inspection, and internal review trace by default.
Protocol and submission integrity
AI-assisted protocol drafting, amendment reasoning, and regulatory-submission synthesis carry sealed provenance for source data, version state, and human authority. Deterministic guardrails prevent silent scope drift on regulated documentation.
Pharmacovigilance and safety posture
Case intake, signal detection, narrative drafting, and periodic-report synthesis pass through the runtime with provenance and human-authority checkpoints preserved. Safety signals carry the sealed chain from source report to reviewed disposition.
Reagent and chain-of-custody provenance
Reagent qualification, chain-of-custody records, cold-chain excursion signals, and specimen provenance carry the same evidence chain as the AI actions that reason over them. Sponsor and site operations reach one authoritative record.
Sovereign deployment
On-premise, private-cloud, or hybrid sovereign deployment for sponsors and manufacturers that cannot expose sequence data, patient-derived material metadata, or process IP to a vendor cloud. Evidence store and constitutional runtime run inside the boundary you already validate.
Where governance meets the research and translational lifecycle
Biotech and translational organizations compound risk when AI is retrofitted onto research, quality, and pharmacovigilance surfaces. ETHRAEON is designed for the classes of decision where scientific integrity, sponsor obligation, and audit trail all matter.
- Research and translational reasoning. AI-assisted literature synthesis, target-and-mechanism reasoning, and experimental-design drafting carry sealed provenance: input tags, model version, guardrail state, and human authority for edge-case escalation.
- Process development and batch review. Batch-history reasoning, deviation triage, and process-development synthesis pass through the constitutional runtime with quality posture enforced by construction.
- Clinical operations and safety review. Case narrative drafting, adverse-event aggregation, and periodic-report synthesis record the reasoning chain from source report to reviewed disposition.
- Regulatory submission assembly. Module drafting, cross-reference reconciliation, and version-anchored submission assembly carry hash-chained provenance from source dataset to filed artifact.
Proof surface
ETHRAEON runs its own operations under constitutional governance. 300 plus production surfaces, 700 plus governance directives executed and evidenced, a hash-chained evidence store, and a substrate registry that reports live status. The infrastructure is the demonstration.
Engagement
Biotech engagements start with a governance briefing scoped to your research and development portfolio, quality posture, and current AI deployment surface. The briefing produces a written architecture assessment and a deployment path proposal. From there: pilot inside a validated environment, evidenced production integration, or sovereign private-cloud install.
Portfolio anchors
ETHRAEON is a constitutional runtime and evidence control layer. Portfolio posture: 16 U.S. provisional filings, 73 specifications, 9 families. Public claims are calibrated. AGI-class and ASI-class positioning is architectural, not an achievement claim. This surface describes commercial capability posture. It is not a representation of clinical outcome, regulatory approval, or intended therapeutic use for any specific product. Sponsors and manufacturers retain full responsibility for regulatory compliance of their own programs.